IT1229075B
(it)
*
|
1985-04-05 |
1991-07-17 |
Fidia Farmaceutici |
Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
|
CA1340994C
(en)
*
|
1989-09-21 |
2000-05-16 |
Rudolf Edgar Dr. Falk |
Treatment of conditions and disease
|
US5639738A
(en)
*
|
1992-02-20 |
1997-06-17 |
Hyal Pharmaceutical Corporation |
Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
|
US5990096A
(en)
*
|
1990-09-18 |
1999-11-23 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US5824658A
(en)
*
|
1990-09-18 |
1998-10-20 |
Hyal Pharmaceutical Corporation |
Topical composition containing hyaluronic acid and NSAIDS
|
US5910489A
(en)
*
|
1990-09-18 |
1999-06-08 |
Hyal Pharmaceutical Corporation |
Topical composition containing hyaluronic acid and NSAIDS
|
CA2061703C
(en)
*
|
1992-02-20 |
2002-07-02 |
Rudolf E. Falk |
Formulations containing hyaluronic acid
|
US5610148A
(en)
*
|
1991-01-18 |
1997-03-11 |
University College London |
Macroscopically oriented cell adhesion protein for wound treatment
|
US5629287A
(en)
*
|
1991-01-18 |
1997-05-13 |
University College London |
Depot formulations
|
JP2829794B2
(ja)
*
|
1991-02-08 |
1998-12-02 |
エスエス製薬 株式会社 |
徐放性経口投与型プラノプロフェン製剤
|
US6103704A
(en)
*
|
1991-07-03 |
2000-08-15 |
Hyal Pharmaceutical Corporation |
Therapeutic methods using hyaluronic acid
|
US5792753A
(en)
*
|
1991-07-03 |
1998-08-11 |
Hyal Pharmaceutical Corporation |
Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
|
US5977088A
(en)
*
|
1991-07-03 |
1999-11-02 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US5990095A
(en)
*
|
1991-07-03 |
1999-11-23 |
Hyal Pharmaceutical Corporation |
Use of hyaluronic acid and forms to prevent arterial restenosis
|
US5817644A
(en)
*
|
1991-07-03 |
1998-10-06 |
Hyal Pharmaceutical Corporation |
Targeting of dosages of medicine and therapeutic agents
|
CA2122551A1
(en)
*
|
1994-04-29 |
1995-10-30 |
Rudolf Edgar Falk |
Clearing of atherosclerosis
|
JPH06509099A
(ja)
*
|
1991-07-03 |
1994-10-13 |
サノ・コーポレーシヨン |
ジクロフエナツクの経皮デリバリーに対する組成物及び方法
|
US5817642A
(en)
*
|
1991-07-03 |
1998-10-06 |
Hyal Pharmaceutical Corporation |
Clearing of atherosclerosis
|
US6147059A
(en)
*
|
1992-02-20 |
2000-11-14 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
CA2061567C
(en)
*
|
1992-02-20 |
1998-02-03 |
Rudolf E. Falk |
Use of hyaluronic acid to repair ischemia reperfusion damage
|
US6218373B1
(en)
|
1992-02-20 |
2001-04-17 |
Hyal Pharmaceutical Corporation |
Formulations containing hyaluronic acid
|
US5767106A
(en)
*
|
1992-02-21 |
1998-06-16 |
Hyal Pharmaceutical Corporation |
Treatment of disease and conditions associated with macrophage infiltration
|
US6114314A
(en)
*
|
1992-02-21 |
2000-09-05 |
Hyal Pharmaceutical Corp. |
Formulations containing hyaluronic acid
|
CA2094203A1
(en)
*
|
1993-04-16 |
1994-10-17 |
Derek A. Willoughby |
Inhibition of angiogenesis
|
US5847002A
(en)
*
|
1993-04-16 |
1998-12-08 |
Hyal Pharmaceutical Corporation |
Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID
|
GB9425487D0
(en)
*
|
1994-12-16 |
1995-02-15 |
Res Inst |
Osteoarthritis treatment
|
US5939047A
(en)
*
|
1996-04-16 |
1999-08-17 |
Jernberg; Gary R. |
Local delivery of chemotherapeutic agents for treatment of periodontal disease
|
US20030008396A1
(en)
*
|
1999-03-17 |
2003-01-09 |
Ku David N. |
Poly(vinyl alcohol) hydrogel
|
CN100374163C
(zh)
|
1999-01-13 |
2008-03-12 |
阿尔凯米亚肿瘤学私人有限公司 |
增强药物功效的组合物
|
US6645485B2
(en)
*
|
2000-05-10 |
2003-11-11 |
Allan R. Dunn |
Method of treating inflammation in the joints of a body
|
AUPQ879500A0
(en)
*
|
2000-07-14 |
2000-08-10 |
Meditech Research Limited |
Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
|
US9066919B2
(en)
|
2000-07-14 |
2015-06-30 |
Alchemia Oncology Pty Limited |
Hyaluronan as a chemo-sensitizer in the treatment of cancer
|
US6726898B2
(en)
|
2000-11-17 |
2004-04-27 |
Gary R. Jernberg |
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
|
US6576226B1
(en)
|
2000-11-17 |
2003-06-10 |
Gary R. Jernberg |
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
|
CA2436739A1
(en)
*
|
2000-12-26 |
2002-07-04 |
Takeda Chemical Industries, Ltd. |
Combination agent
|
CA2440744C
(en)
*
|
2001-03-15 |
2009-12-08 |
Seikagaku Corporation |
Il-12 expression controlling agent
|
JP2004535434A
(ja)
*
|
2001-06-25 |
2004-11-25 |
デピユイ |
関節炎にかかった関節の処置のためのグリコサミノグリカン類のリポソームカプセル化
|
DE60234057D1
(de)
|
2001-07-25 |
2009-11-26 |
Raptor Pharmaceutical Inc |
Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
|
JP2005505540A
(ja)
*
|
2001-08-27 |
2005-02-24 |
メディテック リサーチ リミテッド |
改善された治療プロトコール
|
BR0212244A
(pt)
*
|
2001-08-30 |
2004-10-05 |
Merckle Gmbh |
Uso de um ou mais do que um composto e seus isÈmeros ópticos, derivados e sais fisiologicamente aceitáveis, composição farmacêutica, e, método de tratamento ou de prevenção da degeneração ou da destruição de cartilagem articular e/ou de osso subcondral em uma ou mais articulações de um mamìfero
|
EP1507543A4
(en)
*
|
2002-05-09 |
2006-07-26 |
Cambridgemed Inc |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF WOOD WITH BLOOD PLASMA OR SERUM
|
US8273347B2
(en)
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
US7429378B2
(en)
*
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
US7553827B2
(en)
*
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
US7344716B2
(en)
*
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
US20040229878A1
(en)
*
|
2003-05-13 |
2004-11-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of P38 kinase
|
US8361467B2
(en)
*
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
US8895540B2
(en)
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
AU2005205422B2
(en)
*
|
2004-01-20 |
2008-04-24 |
Panacea Biotec Ltd. |
Compostions comprising glycosaminoglycan and nonsteroidal anti-inflammatory drug
|
US7910124B2
(en)
*
|
2004-02-06 |
2011-03-22 |
Georgia Tech Research Corporation |
Load bearing biocompatible device
|
EP1786485A4
(en)
|
2004-02-06 |
2012-05-30 |
Georgia Tech Res Inst |
CELLULAR IMPLANTATION WITH SURFACE ADHESION
|
US7956180B2
(en)
*
|
2004-05-27 |
2011-06-07 |
Novozymes A/S |
Dried and agglomerated hyaluronic acid product
|
EP1753810B1
(en)
*
|
2004-05-27 |
2013-08-14 |
Novozymes Biopharma DK A/S |
A dried and agglomerated hyaluronic acid product
|
US20050278025A1
(en)
*
|
2004-06-10 |
2005-12-15 |
Salumedica Llc |
Meniscus prosthesis
|
US20060122150A1
(en)
*
|
2004-09-30 |
2006-06-08 |
Argentieri Dennis C |
Pharmaceutical composition and method for treating a joint-capsule arthropathy
|
SI1889198T1
(sl)
|
2005-04-28 |
2015-02-27 |
Proteus Digital Health, Inc. |
Farma-informacijski sistem
|
CN103784960A
(zh)
|
2005-07-27 |
2014-05-14 |
阿尔卡米亚肿瘤学股份有限公司 |
使用乙酰透明质酸的治疗方案
|
US7323184B2
(en)
*
|
2005-08-22 |
2008-01-29 |
Healagenics, Inc. |
Compositions and methods for the treatment of wounds and the reduction of scar formation
|
CA2621279C
(en)
*
|
2005-09-07 |
2016-06-14 |
Alchemia Oncology Pty Limited |
Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
|
US9492381B1
(en)
|
2005-11-10 |
2016-11-15 |
Reyn Pharma, Llc |
Method of administering hyaluronan formulation for preventing and ameliorating osteoarthritis
|
US8598144B1
(en)
|
2005-11-10 |
2013-12-03 |
Reyn Pharma, Llc |
Method of administering hyaluronan formulation for the amelioration of osteoarthritis
|
ES2621876T3
(es)
*
|
2006-09-13 |
2017-07-05 |
Enhance Skin Products Inc. |
Composición cosmética para el tratamiento de la piel y procedimientos de la misma
|
MX2009002893A
(es)
|
2006-09-18 |
2009-07-10 |
Raptor Pharmaceutical Inc |
Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
|
FR2918276B1
(fr)
*
|
2007-07-02 |
2010-01-22 |
Anteis Sa |
"utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
|
FR2918476B1
(fr)
*
|
2007-07-02 |
2012-08-03 |
Experts Enlargement Quality Exeq |
Controle de conformite de donnees.
|
US8986696B2
(en)
*
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
US20090162351A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Depuy Spine, Inc. |
Transdiscal administration of inhibitors of p38 MAP kinase
|
US8178511B1
(en)
*
|
2008-07-02 |
2012-05-15 |
Smith James D |
Method of administering hyaluronan formulation for the amelioration of osteopenia
|
WO2010095940A2
(en)
|
2009-02-20 |
2010-08-26 |
To-Bbb Holding B.V. |
Glutathione-based drug delivery system
|
NZ596876A
(en)
|
2009-05-06 |
2014-01-31 |
Lab Skin Care Inc |
Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
|
FR2945949B1
(fr)
*
|
2009-05-26 |
2011-05-13 |
Anteis Sa |
Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme.
|
IL206739A
(en)
|
2010-06-30 |
2016-06-30 |
David Segal |
An injectable drug containing silitol as an active substance
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
TWI382841B
(zh)
*
|
2010-10-29 |
2013-01-21 |
Univ China Medical |
用於抑制發炎之醫藥組合物
|
WO2012162552A1
(en)
|
2011-05-26 |
2012-11-29 |
Cartiva, Inc. |
Tapered joint implant and related tools
|
PT2543357T
(pt)
*
|
2011-07-07 |
2018-04-30 |
Holy Stone Healthcare Co Ltd |
Resumo
|
EP3892241A1
(en)
|
2015-03-31 |
2021-10-13 |
Cartiva, Inc. |
Drill bit for carpometacarpal implant
|
WO2016161025A1
(en)
|
2015-03-31 |
2016-10-06 |
Cartiva, Inc. |
Hydrogel implants with porous materials and methods
|
AU2016248062B2
(en)
|
2015-04-14 |
2020-01-23 |
Cartiva, Inc. |
Tooling for creating tapered opening in tissue and related methods
|